Literature DB >> 6434125

Immune response of neonates to oral poliomyelitis vaccine.

T J John.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6434125      PMCID： PMC1443408          DOI： 10.1136/bmj.289.6449.881

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  THE RELATIONSHIP OF MATERNAL ANTIBODY, BREAST FEEDING, AND AGE TO THE SUSCEPTIBILITY OF NEWBORN INFANTS TO INFECTION WITH ATTENUATED POLIOVIRUSES.

Authors:  R J WARREN; M L LEPOW; G E BARTSCH; F C ROBBINS
Journal:  Pediatrics       Date:  1964-07       Impact factor: 7.124

2.  Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination.

Authors:  T J John; L V Devarajan; L Luther; P Vijayarathnam
Journal:  Pediatrics       Date:  1976-01       Impact factor: 7.124

3.  Antibody response of infants in tropics to five doses of oral polio vaccine.

Authors:  T J John
Journal:  Br Med J       Date:  1976-04-03

4.  Appropriate strategy for immunisation of children in India 3. Community-based annual pulse (cluster) immunisation.

Authors:  T J John; M C Steinhoff
Journal:  Indian J Pediatr       Date:  1981 Nov-Dec       Impact factor: 1.967

5.  Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.

Authors:  A B Sabin; A Flores Arechiga; J Fernández de Castro; J L Sever; D L Madden; I Shekarchi; P Albrecht
Journal:  JAMA       Date:  1983-05-20       Impact factor: 56.272
  5 in total
  10 in total

1.  Providing monovalent oral polio vaccine type 1 to newborns: findings from a pilot birth-dose project in Moradabad district, India.

Authors:  J J Rainey; P Bhatnagar; C F Estivariz; S Durrani; M Galway; H Sandhu; S Bahl; H Jafari; J Wenger
Journal:  Bull World Health Organ       Date:  2009-10-01       Impact factor: 9.408

Review 2.  Oral and inactivated poliovirus vaccines in the newborn: a review.

Authors:  Farrah J Mateen; Russell T Shinohara; Roland W Sutter
Journal:  Vaccine       Date:  2012-06-20       Impact factor: 3.641

3.  Preeradication vaccine policy options for poliovirus infection and disease control.

Authors:  Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Jong-Hoon Kim; Stephen L Cochi
Journal:  Risk Anal       Date:  2013-03-05       Impact factor: 4.000

4.  Seroconversion following killed polio vaccine in neonates.

Authors:  P K Jain; A K Dutta; S Nangia; S Khare; A Saili
Journal:  Indian J Pediatr       Date:  1997 Jul-Aug       Impact factor: 1.967

5.  Revised immunisation schedule of the WHO expanded programme on immunisation.

Authors:  T J John
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

Review 6.  The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.

Authors:  N Halsey; A Galazka
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

7.  Polio vaccination of the newborn.

Authors:  T J John
Journal:  Indian J Pediatr       Date:  1985 Jul-Aug       Impact factor: 1.967

8.  Effect of passively transferred anti-poliovirus antibodies on seroconversion.

Authors:  S B Bavdekar; S Naik; S S Nadkarni; J R Kamat; J M Deshpande; L K Vaswani
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

9.  Oral polio vaccination in infants: beneficial effect of additional dose at birth.

Authors:  S Khare; S Kumari; I S Nagpal; D Sharma; T Verghese
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

10.  Neonatal vitamin A supplementation associated with a cluster of deaths and poor early growth in a randomised trial among low-birth-weight boys of vitamin A versus oral polio vaccine at birth.

Authors:  Najaaraq Lund; Sofie Biering-Sørensen; Andreas Andersen; Ivan Monteiro; Luis Camala; Mathias Jul Jørgensen; Peter Aaby; Christine Stabell Benn
Journal:  BMC Pediatr       Date:  2014-08-28       Impact factor: 2.125
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.